论文部分内容阅读
目的:探讨东菱迪芙(Batroxobin)在常规剂量下,对深静脉血栓后遗症期患者的预后的影响。方法:按预先制定的标准,随机选择50例患者,按照规定方案治疗,测定和记录结果并进行统计学分析。结果:治疗前后患者下肢的肿胀感、疼痛感显著改善,肢体周径缩小,陈旧性血栓缩小,东菱迪芙组的总有效率为94.3%,具有统计学意义,具有良好的使用安全性。结论:通过降低患者的高凝状态,溶解陈旧性血栓,减轻深静脉血栓后遗症的程度。
Objective: To investigate the effect of Batroxobin on the prognosis of patients with deep venous thrombosis after conventional treatment. Methods: According to pre-established criteria, 50 patients were randomly selected and treated according to prescribed protocols. The results were measured and recorded and statistically analyzed. Results: Before and after treatment, the feeling of swelling and pain of the lower extremities of patients were significantly improved. The circumference of the limbs was reduced and the old thrombus was reduced. The total effective rate of Donglingdufu group was 94.3%, which was statistically significant and had good safety of use. Conclusion: By reducing the hypercoagulability of patients, dissolve the old thrombus, reduce the degree of deep venous thrombosis sequelae.